(Q37738105)

22 August 2017

1 reference

title

Remission in juvenile idiopathic arthritis: current facts (English)

1 reference

juvenile rheumatoid arthritis

22 August 2017

1 reference

Susan Shenoi

1

1 reference

PubMed ID

20425015

22 August 2017

Carol A Wallace

series ordinal

2

1 reference

22 August 2017

1 April 2010

1 reference

Current Rheumatology Reports

22 August 2017

1 reference

22 August 2017

12

1 reference

22 August 2017

2

1 reference

22 August 2017

80-86

1 reference

https://scigraph.springernature.com/pub.10.1007/s11926-010-0085-2

22 August 2017

0 references

cites work

Optimal treatment of knee monarthritis in juvenile idiopathic arthritis: a decision analysis

1 reference

12 December 2020

Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis

1 reference

12 December 2020

Remission status follow-up in children with juvenile idiopathic arthritis

1 reference

12 December 2020

A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate

1 reference

12 December 2020

Quantitative alterations of CD8+ T cells in juvenile idiopathic arthritis patients in remission

1 reference

12 December 2020

Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: Results from a twe

1 reference

12 December 2020

Inactive disease in polyarticular juvenile idiopathic arthritis: current patterns and associations

1 reference

12 December 2020

Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission

1 reference

12 December 2020

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

1 reference

12 December 2020

Juvenile rheumatoid arthritis: outcome and treatment for the 1990s

1 reference

12 December 2020

Theoretical and practical basis for early aggressive therapy in paediatric autoimmune disorders

1 reference

12 December 2020

Assessing remission in clinical practice

1 reference

12 December 2020

Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score

1 reference

12 December 2020

Infliximab in active early rheumatoid arthritis

1 reference

12 December 2020

Juvenile chronic arthritis into adulthood: a long-term follow-up study.

1 reference

12 December 2020

Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritis

1 reference

12 December 2020

Tumor necrosis factor inhibitors in the management of juvenile idiopathic arthritis: an evidence-based review

1 reference

12 December 2020

Predicting remission in juvenile rheumatoid arthritis with methotrexate treatment.

1 reference

12 December 2020

Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria

1 reference

12 December 2020

Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis.

1 reference

12 December 2020

Treating rheumatoid arthritis early: a window of opportunity?

1 reference

12 December 2020

Clinical remission in patients with systemic juvenile idiopathic arthritis treated with anti-tumor necrosis factor agents.

1 reference

12 December 2020

Defining remission in rheumatoid arthritis: results of an initial American College of Rheumatology/European League Against Rheumatism consensus conference

1 reference

12 December 2020

The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis

1 reference

12 December 2020

Assessing current outcomes of juvenile idiopathic arthritis: a cross-sectional study in a tertiary center sample

1 reference

12 December 2020

New advances in the management of juvenile idiopathic arthritis--2: the era of biologicals

1 reference

12 December 2020

Remission in rheumatoid arthritis: wishful thinking or clinical reality?

1 reference

12 December 2020

Treatment strategies for juvenile idiopathic arthritis

1 reference

12 December 2020

Preliminary validation of clinical remission criteria using the OMERACT filter for select categories of juvenile idiopathic arthritis.

1 reference

12 December 2020

Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score

1 reference

12 December 2020

Prognosis of patients with juvenile chronic arthritis and juvenile spondyloarthropathy.

1 reference

12 December 2020

Preliminary criteria for clinical remission in rheumatoid arthritis

1 reference

12 December 2020

Accuracy of Wallace criteria for clinical remission in juvenile idiopathic arthritis: a cohort study of 761 consecutive cases.

1 reference

12 December 2020

Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis?

1 reference

12 December 2020

Early rheumatoid arthritis: a medical emergency?

1 reference

12 December 2020

Achievement of a State of Inactive Disease at Least Once in the First 5 Years Predicts Better Outcome of Patients with Polyarticular Juvenile Idiopathic Arthritis

1 reference

12 December 2020

The meaning of clinical remission in polyarticular juvenile idiopathic arthritis: gene expression profiling in peripheral blood mononuclear cells identifies distinct disease states

1 reference

12 December 2020

Understanding the window of opportunity concept in early rheumatoid arthritis

1 reference

12 December 2020

Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort.

1 reference

12 December 2020

Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: sustained benefits of early sulfasalazine treatment

1 reference

12 December 2020

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

1 reference

12 December 2020

Patterns of clinical remission in select categories of juvenile idiopathic arthritis.

1 reference

12 December 2020

Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis.

1 reference

12 December 2020

Long-term follow-up of 246 adults with juvenile idiopathic arthritis: functional outcome

1 reference

12 December 2020

Complexities in defining remission in rheumatic diseases

1 reference

12 December 2020

The use of methotrexate in childhood rheumatic diseases

1 reference

12 December 2020

Can remission be maintained with or without further drug therapy in rheumatoid arthritis?

1 reference

12 December 2020

What should be our treatment goal in rheumatoid arthritis today?

1 reference

12 December 2020

10.1007/S11926-010-0085-2

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20425015